Search results
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 1 day agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 1 day agoCAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been notified by the U.S. Food and Drug Administration (FDA) that due to administrative ...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 22 hours agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 19 hours agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 1 day agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 11 hours agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most recent filing ...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 1 day agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 1 day agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Quick takes: Moderna's RSV vaccine, flu-COVID combo vaccines, new polio cases
Center for Infectious Disease Research and Policy· 4 hours agoThe FDA has pushed back its review of Moderna's RSV vaccine owing to administrative issues.
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 1 day agoModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for...